U.S. markets open in 49 minutes

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.8600-0.0900 (-1.82%)
At close: 4:00PM EDT
4.9000 +0.04 (0.82%)
Pre-Market: 07:53AM EDT

Ekso Bionics Holdings, Inc.

1414 Harbour Way South
Suite 1201
Richmond, CA 94804
United States
510 984 1761
http://www.eksobionics.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees39

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven A. ShermanExec. Chairman100kN/A1946
Mr. Jack PeurachPres, CEO & Director366.72kN/A1966
Mr. John F. GlennCFO & Sec.332kN/A1962
Mr. William R. ShawChief Commercial Officer402.14kN/A1974
Ms. Rachael AdamsGlobal Director of Marketing & Strategic GrowthN/AN/AN/A
Mr. Anthony PrattUS Director of SalesN/AN/AN/A
Ms. Foon Lim ChweePres of APACN/AN/AN/A
Mr. Jerome WongCorp. ControllerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.

Corporate Governance

Ekso Bionics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.